DrugPatentWatch Database Preview
Drugs in Development Information for Hepatitis A Vaccine
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Hepatitis A Vaccine?
Hepatitis A Vaccine is an investigational drug.
There have been 4 clinical trials for Hepatitis A Vaccine.
The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2011.
The most common disease conditions in clinical trials are HIV Infections, Urinary Bladder Neoplasms, and Colonic Neoplasms. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), MacroGenics, and National Cancer Institute (NCI).
There are thirteen US patents protecting this investigational drug and two hundred and fifty-two international patents.
Summary for Hepatitis A Vaccine
| US Patents | 13 |
| International Patents | 252 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2011-04-01) |
| Vendors | 0 |
Recent Clinical Trials for Hepatitis A Vaccine
| Title | Sponsor | Phase |
|---|---|---|
| Phase 1 Study of MGD010 in Healthy Subjects | MacroGenics | Phase 1 |
| Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | National Cancer Institute (NCI) | Phase 2 |
| A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Clinical Trial Summary for Hepatitis A Vaccine
Top disease conditions for Hepatitis A Vaccine
Top clinical trial sponsors for Hepatitis A Vaccine
US Patents for Hepatitis A Vaccine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Hepatitis A Vaccine | Start Trial | Cell culture of hepatitis A virus | Merck & Co., Inc. (Rayway, NJ) | Start Trial |
| Hepatitis A Vaccine | Start Trial | Liquid formulations for proteinic pharmaceuticals | Start Trial | |
| Hepatitis A Vaccine | Start Trial | Cell culture of hepatitis A virus | Merck & Co., Inc. (Rahway, NJ) | Start Trial |
| Hepatitis A Vaccine | Start Trial | Chimeric hepatitis A vaccine | The United of America as represented by the Department of Health and Human Services (Washington, DC) | Start Trial |
| Hepatitis A Vaccine | Start Trial | Attenuated hepatitis a virus vaccine which grows in MRC-5 cells | The United States of America as represented by the Department of Health and Human Services (Washington, DC) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Hepatitis A Vaccine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Hepatitis A Vaccine | Australia | 5642396 | 2015-05-16 | Start Trial |
| Hepatitis A Vaccine | Canada | 2210996 | 2015-05-16 | Start Trial |
| Hepatitis A Vaccine | European Patent Office | 0813421 | 2015-05-16 | Start Trial |
| Hepatitis A Vaccine | World Intellectual Property Organization (WIPO) | 9636352 | 2015-05-16 | Start Trial |
| Hepatitis A Vaccine | Austria | 8409 | 1999-09-04 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
